Detalles de la búsqueda
1.
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
Circulation
; 147(25): 1933-1944, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335828
2.
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
Eur Heart J
; 43(10): 959-967, 2022 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34918066
3.
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Lancet
; 397(10283): 1470-1483, 2021 04 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865495
4.
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.
J Thromb Thrombolysis
; 54(3): 461-469, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36048358
5.
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
J Thromb Thrombolysis
; 54(3): 373-381, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036856
6.
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor.
J Thromb Thrombolysis
; 51(3): 741-747, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582955
7.
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Circulation
; 139(14): 1661-1670, 2019 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30630341
8.
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Circulation
; 137(23): 2450-2462, 2018 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29526833
9.
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies.
Circulation
; 136(20): 1955-1975, 2017 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29084738
10.
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention.
J Transl Med
; 16(1): 92, 2018 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29642909
11.
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Circulation
; 134(11): 780-92, 2016 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27559041
12.
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
Eur Heart J
; 37(35): 2722-30, 2016 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26848148
13.
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study.
Circulation
; 142(15): 1500-1502, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044856
14.
Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease.
Circ J
; 80(4): 791-801, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26984587
15.
Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable patients with CAD treated with dual ANtiplatelet therapy) study.
J Thromb Thrombolysis
; 40(3): 331-9, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25761430
16.
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.
J Thromb Thrombolysis
; 40(1): 118-25, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25129122
17.
Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention: Finding the Balance for Patients With Stable Coronary Artery Disease.
Circulation
; 138(13): 1301-1303, 2018 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354428
18.
Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery.
Curr Opin Cardiol
; 29(6): 553-63, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25144343
19.
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation.
J Thromb Thrombolysis
; 37(2): 131-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23943337
20.
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thromb Haemost
; 124(3): 263-273, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37224883